Purchase Order 75D30123P17181

Award Date 9/18/23
Potential Completion Date 9/17/24
Potential Value $191K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Saranac Lake, NY, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Bionique Testing Laboratories LLC was awarded a firm fixed price purchase order valued at $68,826 by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, Pennsylvania. The contract is for mycoplasma testing laboratory services to support CDC infectious disease prevention and control programs. Bionique Testing Laboratories will utilize its laboratory facilities located in Saranac Lake, New York to provide the specialized diagnostic testing. No set aside designation or...
The U.S. Centers for Disease Control and Prevention (CDC) in Pittsburgh, Pennsylvania has awarded a $68,040.00 firm-fixed-price purchase order to Nelson Laboratories, LLC, a for-profit limited liability company, to provide laboratory services. This award has no set-aside designation and is scheduled for completion by September 29, 2024. Nelson Laboratories is an experienced federal contractor that has received multiple prime contracts and subcontracts from agencies like the CDC, Indian Health...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $145,252.00 firm-fixed-price purchase order contract to Bioniquest Lab Services, Inc., a for-profit subchapter S corporation. The contract, called BIONIQUEST, is for equipment maintenance services to support federal research and healthcare programs. Services include preventative maintenance, breakdown response, diagnostics, critical part replacements, and software support for laboratory instruments...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $49,900 firm fixed price purchase order to Bionano Genomics, Inc. of San Diego, California for the delivery of a purification system. The contract is being carried out from September 14, 2023 through October 30, 2023 to support the CDC's efforts. No subcontractors or set aside designations were indicated. The award provides Bionano Genomics the opportunity to supply specialized...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $51,390.81 purchase order contract to Innopsys, Inc. for biomedical equipment. The contract has a period of performance from August 10, 2023 to September 7, 2023 and is a firm fixed price award. It was awarded under a total small business set aside. Per the solicitation, Innopsys will provide its InnoScan 710 product to support CDC programs. As the nation's health protection agency, CDC...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $134,109.65 purchase order to Qiagen, LLC for laboratory supplies. Qiagen, LLC is a division of Qiagen N.V., which will serve as the prime contractor. The contract has a firm fixed price and period of performance from July 25, 2023 through July 25, 2024. No additional details were provided on the requested products or services, however based on the funding agency, the laboratory...
This federal contract award is for BIOFIRE LAB SUPPLIES, valued at $132,525.00, awarded to Biofire Diagnostics LLC, a foreign-owned, for-profit biotech company, by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) Pittsburgh office. The contract is a firm-fixed price purchase order with an award date of September 17, 2019 and a completion date of October 16, 2019. No set-aside designation was used. Biofire Diagnostics LLC is a leader in syndromic...
This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to MS Bioworks LLC, a for-profit limited liability company, for proteomic analysis services. The $83,998.60 firm fixed-price purchase order contract has a period of performance ending on June 30, 2020. The original contract opportunity was a small business set-aside solicitation that allowed for a reverse auction conducted through the Unison Marketplace platform. MS Bioworks LLC has previously provided...
This is a $248,779.00 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Bioreliance Corporation, a foreign-owned for-profit organization. The contract is for follow-up in vivo oncogenicity testing on the Expi293F Master Cell Bank to support the CDC's influenza vaccine development efforts. The testing must be compliant with 21 CFR and current Good Laboratory Practices (cGLP) and is expected to be completed within 24 weeks. This contract was not set...
This is a $30,000.00 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to MS Bioworks LLC, a for-profit limited liability company located in Ann Arbor, Michigan. The contract is for pulmonary tissue analysis services, which aligns with the CDC's mission in public health monitoring and biomedical research. The contract does not have a set-aside designation. MS Bioworks, which is registered in the System for Award Management (SAM) and has...

The U.S. Centers for Disease Control and Prevention (CDC) in Pittsburgh, Pennsylvania awarded a $190,699.20 firm fixed price purchase order to Bionique Testing Laboratories LLC, doing business as Bionique, for mycoplasma testing services. Bionique has provided these specialized diagnostic testing services to the CDC over multiple years to support the agency's infectious disease prevention and control programs. The contract has an ultimate completion date of September 17, 2024. No set-aside designation was indicated in the award details provided.

Generated 6/22/24, 9:27 AM